Moreover, considering the elevated FOXP3, IL-6, and IL-17 levels in these cells, CML cell-derived exosomes may induce T cell fate toward tumor favorable T cells instead of conventional activated T cells (Th1, Th2, CTL, etc.)[18, 29]. This evidence concerns the gene IL17A and chronic myelogenous leukemia, BCR-ABL1 positive.